Download PDF
Am J Perinatol 2000; 17(8): 429-436
DOI: 10.1055/s-2000-13458
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

MANAGEMENT OF THE INFANT BORN TO A MOTHER INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1): CURRENT CONCEPTS

Aracelis D. Fernandez, David F. McNeeley
  • Division of Pediatric Infectious Diseases and Immunology, Weill Medical College of Cornell University, New York, New York
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

Despite the use of highly active antiretroviral therapy (HAART) and the success of protocol PACTG-076 in decreasing perinatal transmission of HIV infection in many industrialized countries, a total of 5,600,000 new cases of HIV infection were diagnosed worldwide in 1999. Of those cases, more than 10% are children under 15 years of age. The vast majority of pediatric HIV infection is due to perinatal transmission. More than 95% of HIV-infected people live in the developing world. Different studies are currently being conducted with modifications of the original PACTG-076, especially shorter courses of zidovudine (ZDV), combinations of antiretrovirals (ZDV and 3TC), or comparison of a modified version of the standard ZDV course vs. a single dose of nevirapine for the mother intrapartum and also for the newborn. The results of these studies may provide more affordable, alternative regimens to prevent maternal-to-child HIV-1 transmission for developing countries than the PACTG-076 protocol. It is very important that physicians and physician extenders (nurse practitioners and physician assistants) caring for infants born to HIV-infected mothers have an understanding of the pathophysiology of vertical HIV-1 infection transmission. They should be familiar with the conditions associated with an increased risk of transmission, interventions available to decrease this risk, current medications, and laboratory resources.

KEYWORD

Pediatric HIV infection - pediatric AIDS - perinatal transmission of HIV

REFERENCES

  • 1 AIDS Epidemic Update, December. WHO/UNAIDS 1999
    Google Scholar
  • 2 Pape J W, Deschamps M M, Verdier R I. The urge for an AIDS vaccine: perspectives from a developing country.  AIDS Res Hum Retroviruses . 1992;  8 1535-1537
    PubMedGoogle Scholar
  • 3 Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus.  N Engl J Med . 1995;  333 298-302
    CrossrefPubMedGoogle Scholar
  • 4 Wilfert C M. Perinatal HIV transmission-a global-problem: controversy and protection of the next generation.  Semin Pediatr Infect Dis . 1998;  9 339-344
    PubMedGoogle Scholar
  • 5 Johann-Liang R, Cervia J S, Noel G J. Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s.  Pediatr Infect Dis J . 1997;  16 1145-1150
    CrossrefPubMedGoogle Scholar
  • 6 The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies.  J Acquir Immune Defic Syndr Hum Retroviral . 1995;  8 506-510
    PubMedGoogle Scholar
  • 7 The European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors.  AIDS . 1996;  10 1675-1681
    PubMedGoogle Scholar
  • 8 Burns D N, Landesman S, Muenz L R. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels.  J Acquir Immune Defic Syndr . 1994;  7 718-726
    PubMedGoogle Scholar
  • 9 Hengel R L, Kennedy M S, Steketee R W. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1.  AIDS Res Hum Retroviruses . 1998;  14 475-481
    PubMedGoogle Scholar
  • 10 Pelliccia P, Galli L, de Martino M. Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein.  AIDS . 2000;  14 F41-F45
    CrossrefPubMedGoogle Scholar
  • 11 Mofenson L M, Lambert J S, Stiehm E R. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine.  N Engl J Med . 1999;  341 385-393
    PubMedGoogle Scholar
  • 12 Soeiro R, Rubinstein A, Rashbaum W K, Lyman W D. Materno-fetal transmission of AIDS: frequency of HIV-1 nucleic acid sequences in human fetal DNA.  J Infect Dis . 1992;  166 699-703
    PubMedGoogle Scholar
  • 13 De Andreis C, Simoni G, Rossella F. HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis.  AIDS . 1996;  10 711-715
    PubMedGoogle Scholar
  • 14 Dunn D T, Brandt C D, Krivine A. The sensitivity of HIV-1-DNA PCR in the neonate period and the relative contributions of intrauterine and intrapartum transmission.  AIDS . 1995;  9 F7-F11
    PubMedGoogle Scholar
  • 15 Brossard Y, Aubin J-T, Mandelbrot L. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses.  AIDS . 1995;  9 359-366
    PubMedGoogle Scholar
  • 16 Ehrnst A, Lindgren S, Dictor M. HIV in pregnant women and their offspring: evidence for late transmission.  Lancet . 1991;  338 203-207
    CrossrefPubMedGoogle Scholar
  • 17 Shearer W, Quinn T C, LaRussa P. Viral load and disease progression in infants infected with human immunodeficiency virus type 1.  N Engl J Med . 1997;  336 1337-1342
    CrossrefPubMedGoogle Scholar
  • 18 Galli L, de Martino M, Tovo P-A. Onset of clinical signs in children with HIV-1 perinatal infection.  AIDS . 1995;  9 455-461
    PubMedGoogle Scholar
  • 19 Bryson Y J. Perinatal HIV-1 transmission: recent advances and therapeutic interventions.  AIDS . 1996;  33-42 (33-42)
    PubMedGoogle Scholar
  • 20 Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud J P, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and non-pregnant women.  J Acquir Immune Defic Syndr . 1993;  6 72-75
    PubMedGoogle Scholar
  • 21 Goedert J J, Duliege A M, Amos C I, Felton S, Biggar R J, and The International Registry of HIV-exposed Twins. High risk of HIV-1 infection for first-born twins.  Lancet . 1991;  338 1471-1475
    PubMedGoogle Scholar
  • 22 Biggar R J, Miotti P G, Taha T E. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission.  Lancet . 1996;  347 1647-1650
    CrossrefPubMedGoogle Scholar
  • 23 Mandelbrot L, Mayaux M J, Bongain A. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort.  Am J Obstet Gynecol . 1996;  175 661-667
    CrossrefPubMedGoogle Scholar
  • 24 Minkoff H, Burns D, Landesman S. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus.  Am J Obstet Gynecol . 1995;  173 585-589
    CrossrefPubMedGoogle Scholar
  • 25 Nielsen K, Boyer P, Dillon M. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1 specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants.  J Infect Dis . 1996;  173 1001-1004
    PubMedGoogle Scholar
  • 26 Boyer P J, Dillon M, Navaie M. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery.  JAMA . 1994;  271 1925-1930
    CrossrefPubMedGoogle Scholar
  • 27 Landesman S H, Kalish L, Burns D N. Obstetrical factors and the transmission of HIV type 1 from mother to child-WITS.  N Engl J Med . 1996;  334 1617-1623
    CrossrefPubMedGoogle Scholar
  • 28 Committee Opinion. Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection. Committee on Obstetric Practice, American Academy of Obstetrics & Gynecology, Washington, DC, August 1999.
    Google Scholar
  • 29 Van de Perre P. Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?.  J Infect Dis . 1999;  S405-S407 ( S405-S407)
    PubMedGoogle Scholar
  • 30 Dabis F, Leroy V, Castetbon K, Spira R, Newell M-L, Salamon R. Preventing mother-to-chlid transmission of HIV-1 in Africa in the year 2000.  AIDS . 2000;  14 1017-1026
    PubMedGoogle Scholar
  • 31 Tess B T, Rodrigues L C, Newell M L. Sao Paolo Collaborative Study of Vertical Transmission of HIV-1. Breastfeeding among HIV-infected women in Sao Paolo State, Brazil. Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Washington, DC, September 1997 (abstract, p. 14)
    Google Scholar
  • 32 Dunn D T, Newell M L, Ades A E, Peckham C S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding.  Lancet . 1992;  340 585-588
    CrossrefPubMedGoogle Scholar
  • 33 De Martino M, Tovo P-A, Tozzi A E. HIV-1 transmission through breastmilk: appraisal of risk according to duration of feeding.  AIDS . 1992;  6 991-997
    PubMedGoogle Scholar
  • 34 McNeeley D F, Laroche L, Bhutra S, Suarez E, Rao S, Rajegowda B. Newborn screening for human immunodeficiency virus infection in the Bronx, NY, and evolving public health policy.  Am J Perinatol . 1999;  16 503-507
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 CDC. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States.  MMWR . 1998;  47(No. RR-2) 1-30
    PubMedGoogle Scholar
  • 36 Connor E M, Sperling R S, Gelber R, for the Pediatric AIDS Clinical Trials Group Protocol 076 Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.  N Engl J Med . 1994;  331 1173-1180
    CrossrefPubMedGoogle Scholar
  • 37 Sperling R S, Shapiro D E, Coombs R W, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant.  N Engl J Med . 1996;  335 1621-1629
    CrossrefPubMedGoogle Scholar
  • 38 O'Sullivan M J, Boyer P J, Scott G B. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with HIV and their infants: phase I ACTG 082. ZDV Collaborative Working Group.  Am J Gynecol . 1992;  168 1516-1519
    PubMedGoogle Scholar
  • 39 Wade N A, Birkhead G S, Warren B L. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.  N Engl J Med . 1998;  39 1409-1414
    PubMedGoogle Scholar
  • 40 Culnane M, Fowler M G, Lee S S, for the Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women.  JAMA . 1999;  281 151-157
    CrossrefPubMedGoogle Scholar
  • 41 World Health Organization. Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV.  Wkly Epidemiol Rec . 1998;  73 313-314
    PubMedGoogle Scholar
  • 42 Guay L A, Musoke P, Fleming T. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.  Lancet . 1999;  354 795-802
    PubMedGoogle Scholar
  • 43 Saba J. The results of the PETRA intervention trial to prevent perinatal transmission in SubSaharan Africa. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January 31-February 4, 1999. Abstract 57
    Google Scholar
  • 44 Dabis F, Leroy V. Preventing mother-to-child transmission of HIV: practical strategies for developing countries.  AIDS Reader . 2000;  10 241-244
    PubMedGoogle Scholar
  • 45 Andiman W A. Medical management of the pregnant woman infected with human immunodeficiency virus type 1 and her child.  Semin Perinatol . 1998;  22 72-86
    PubMedGoogle Scholar
  • 46 Oleske J, Scott G B, and the Working Group on Antiretroviral Therapy and Medical Management of Infants, Children, and Adolescents with HIV Infection. Antiretroviral therapy and medical management of pediatric HIV infection and 1997 USPHS/IDSA report on the prevention of opportunistic infections in persons infected with human immunodeficiency virus.  Pediatrics . 1998;  1005-1085 (1005-1085)
    PubMedGoogle Scholar
  • 47 Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report .  1996;  8 1-39
    PubMedGoogle Scholar
  • 48 Rodriguez E M, Diaz C, Fowler M G. The clinical management of children perinatally exposed to HIV.  Prim Care . 1997;  24 643-666
    PubMedGoogle Scholar
  • 49 Nelson J D, McCracken Jr H G. AIDS and breastfeeding.  Pediatri Infect Dis J. 1998;  17. Newsletter
    PubMedGoogle Scholar
  • 50 Newell M L. Mechanisms and timing of maternal-to-child transmission of HIV-1.  AIDS . 1998;  12 831-836
    CrossrefPubMedGoogle Scholar
  • 51 Bulterys M, Lepage P. Mother-to-child transmission of HIV.  Curr Opin Pediatr . 1998;  10 143-150
    PubMedGoogle Scholar
      >